Ablynx N.V. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ablynx N.V. with three other
miscellaneous service companies in Europe:
sales of 51.01 million Euro [US$54.79 million]
Basilea Pharmaceutica Limited
(65.04 million Swiss Francs [US$65.10 million]
Innate Pharma S.A.
based in France
(56.16 million Euro [US$60.32 million]
During the year ended December of 2016, sales at
Ablynx N.V. were 85.19 million Euro (US$91.50 million).
increase of 9.9%
versus 2015, when the company's sales were 77.54 million Euro.
This was the fifth consecutive year of sales increases at Ablynx N.V.
(and since 2011, sales have increased a total of 290%).